Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Galectin Therapeutics Inc.
This was a Phase 1, open-label, non-randomized, parallel-group study to determine the effect of hepatic impairment on the PK, safety, and tolerability of a single IV dose of belapectin compared to matched healthy subjects with normal hepatic function.
Age
18–75
Sex
ALL
Healthy volunteers
Accepted